v3.25.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Class A
Class B
Common Stock
Class A
Common Stock
Class B
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 35,870     $ 49 $ 386 $ 356,666 $ (321,231)
Beginning Balance (in shares) at Dec. 31, 2023       4,661 38,661    
Stock-based compensation from options and restricted stock, net of forfeitures 433         433  
Issuance of common stock in connection with prior deferred issuance from acquisition         $ 3 (3)  
Issuance of common stock in connection with prior deferred issuance from acquisition (in shares)         356    
Net income (loss) (1,450)           (1,450)
Ending Balance at Mar. 31, 2024 34,853     $ 49 $ 389 357,096 (322,681)
Ending Balance (in shares) at Mar. 31, 2024       4,661 39,017    
Stock-based compensation from options and restricted stock, net of forfeitures 437         437  
Issuance of common stock upon vesting of restricted stock, (in shares)         4    
Net income (loss) (756)           (756)
Ending Balance at Jun. 30, 2024 34,534     $ 49 $ 389 357,533 (323,437)
Ending Balance (in shares) at Jun. 30, 2024       4,661 39,021    
Beginning Balance at Dec. 31, 2024 32,633     $ 49 $ 390 358,372 (326,178)
Beginning Balance (in shares) at Dec. 31, 2024   4,661 39,025 4,661 39,025    
Stock-based compensation from options and restricted stock, net of forfeitures 455         455  
Issuance of common stock upon exercise of options, and issuance and vesting of restricted stock 268       $ 2 266  
Issuance of common stock upon exercise of options, and issuance and vesting of restricted stock (in shares)         198    
Net income (loss) (1,982)           (1,982)
Ending Balance at Mar. 31, 2025 31,374     $ 49 $ 392 359,093 (328,160)
Ending Balance (in shares) at Mar. 31, 2025       4,661 39,223    
Stock-based compensation from options and restricted stock, net of forfeitures 556         556  
Issuance of common stock upon exercise of options, and issuance and vesting of restricted stock 28       $ 1 27  
Issuance of common stock upon exercise of options, and issuance and vesting of restricted stock (in shares)         24    
Net income (loss) 85           85
Ending Balance at Jun. 30, 2025 $ 32,043     $ 49 $ 393 $ 359,676 $ (328,075)
Ending Balance (in shares) at Jun. 30, 2025   4,661 39,247 4,661 39,247